The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Bio-identical Hormone Replacement Therapy Market Research Report 2024
Synopsis
Bioidentical hormone replacement therapy (BHRT) is the use of hormones that are identical on a molecular level with endogenous hormones in hormone replacement therapy.
The global Bio-identical Hormone Replacement Therapy market was valued at US$ 6205 million in 2023 and is anticipated to reach US$ 9405.5 million by 2030, witnessing a CAGR of 6.3% during the forecast period 2024-2030.
The growing frequency of hormonal imbalance illnesses also aids the bioidentical hormone market's expansion. The health safety of the molecule bioidentical hormone, on the other hand, acts as a market restraint. The hormonal levels discovered in a patient with a hormonal imbalance are used to create customised bioidentical hormonal replacements. Additionally, the growing R&D activities by the key players for the discovery of novel therapeutics to treat hormonal imbalances and rising product approvals are expected to aid in the growth of the studied market over the forecast period. However, the high cost of hormone replacement therapy and the risk of developing cancers with HRTs are anticipated to hamper the market growth globally. Additionally, the rise and expansion of the healthcare sector, driven by both public and private actors, particularly in developing nations, will present profitable prospects for the personal health devices market. The market growth rate is also being supported by the governmental healthcare facilities' increased adoption of bioidentical hormone replacement therapy.
This report aims to provide a comprehensive presentation of the global market for Bio-identical Hormone Replacement Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bio-identical Hormone Replacement Therapy.
Report Scope
The Bio-identical Hormone Replacement Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bio-identical Hormone Replacement Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bio-identical Hormone Replacement Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
RevitaLife
SottoPelle
JumpstartMD
BioTE Medical
Aesthetic Everything
Segment by Type
Creams
Injections
Implanted Pellets
Patches
Gels
Segment by Application
Men
Women
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bio-identical Hormone Replacement Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Bioidentical hormone replacement therapy (BHRT) is the use of hormones that are identical on a molecular level with endogenous hormones in hormone replacement therapy.
The global Bio-identical Hormone Replacement Therapy market was valued at US$ 6205 million in 2023 and is anticipated to reach US$ 9405.5 million by 2030, witnessing a CAGR of 6.3% during the forecast period 2024-2030.
The growing frequency of hormonal imbalance illnesses also aids the bioidentical hormone market's expansion. The health safety of the molecule bioidentical hormone, on the other hand, acts as a market restraint. The hormonal levels discovered in a patient with a hormonal imbalance are used to create customised bioidentical hormonal replacements. Additionally, the growing R&D activities by the key players for the discovery of novel therapeutics to treat hormonal imbalances and rising product approvals are expected to aid in the growth of the studied market over the forecast period. However, the high cost of hormone replacement therapy and the risk of developing cancers with HRTs are anticipated to hamper the market growth globally. Additionally, the rise and expansion of the healthcare sector, driven by both public and private actors, particularly in developing nations, will present profitable prospects for the personal health devices market. The market growth rate is also being supported by the governmental healthcare facilities' increased adoption of bioidentical hormone replacement therapy.
This report aims to provide a comprehensive presentation of the global market for Bio-identical Hormone Replacement Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bio-identical Hormone Replacement Therapy.
Report Scope
The Bio-identical Hormone Replacement Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bio-identical Hormone Replacement Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bio-identical Hormone Replacement Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
RevitaLife
SottoPelle
JumpstartMD
BioTE Medical
Aesthetic Everything
Segment by Type
Creams
Injections
Implanted Pellets
Patches
Gels
Segment by Application
Men
Women
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bio-identical Hormone Replacement Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bio-identical Hormone Replacement Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Creams
1.2.3 Injections
1.2.4 Implanted Pellets
1.2.5 Patches
1.2.6 Gels
1.3 Market by Application
1.3.1 Global Bio-identical Hormone Replacement Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Men
1.3.3 Women
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bio-identical Hormone Replacement Therapy Market Perspective (2019-2030)
2.2 Bio-identical Hormone Replacement Therapy Growth Trends by Region
2.2.1 Global Bio-identical Hormone Replacement Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Bio-identical Hormone Replacement Therapy Historic Market Size by Region (2019-2024)
2.2.3 Bio-identical Hormone Replacement Therapy Forecasted Market Size by Region (2025-2030)
2.3 Bio-identical Hormone Replacement Therapy Market Dynamics
2.3.1 Bio-identical Hormone Replacement Therapy Industry Trends
2.3.2 Bio-identical Hormone Replacement Therapy Market Drivers
2.3.3 Bio-identical Hormone Replacement Therapy Market Challenges
2.3.4 Bio-identical Hormone Replacement Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bio-identical Hormone Replacement Therapy Players by Revenue
3.1.1 Global Top Bio-identical Hormone Replacement Therapy Players by Revenue (2019-2024)
3.1.2 Global Bio-identical Hormone Replacement Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Bio-identical Hormone Replacement Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bio-identical Hormone Replacement Therapy Revenue
3.4 Global Bio-identical Hormone Replacement Therapy Market Concentration Ratio
3.4.1 Global Bio-identical Hormone Replacement Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bio-identical Hormone Replacement Therapy Revenue in 2023
3.5 Bio-identical Hormone Replacement Therapy Key Players Head office and Area Served
3.6 Key Players Bio-identical Hormone Replacement Therapy Product Solution and Service
3.7 Date of Enter into Bio-identical Hormone Replacement Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bio-identical Hormone Replacement Therapy Breakdown Data by Type
4.1 Global Bio-identical Hormone Replacement Therapy Historic Market Size by Type (2019-2024)
4.2 Global Bio-identical Hormone Replacement Therapy Forecasted Market Size by Type (2025-2030)
5 Bio-identical Hormone Replacement Therapy Breakdown Data by Application
5.1 Global Bio-identical Hormone Replacement Therapy Historic Market Size by Application (2019-2024)
5.2 Global Bio-identical Hormone Replacement Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Bio-identical Hormone Replacement Therapy Market Size (2019-2030)
6.2 North America Bio-identical Hormone Replacement Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Bio-identical Hormone Replacement Therapy Market Size by Country (2019-2024)
6.4 North America Bio-identical Hormone Replacement Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bio-identical Hormone Replacement Therapy Market Size (2019-2030)
7.2 Europe Bio-identical Hormone Replacement Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Bio-identical Hormone Replacement Therapy Market Size by Country (2019-2024)
7.4 Europe Bio-identical Hormone Replacement Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bio-identical Hormone Replacement Therapy Market Size (2019-2030)
8.2 Asia-Pacific Bio-identical Hormone Replacement Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Bio-identical Hormone Replacement Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Bio-identical Hormone Replacement Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bio-identical Hormone Replacement Therapy Market Size (2019-2030)
9.2 Latin America Bio-identical Hormone Replacement Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Bio-identical Hormone Replacement Therapy Market Size by Country (2019-2024)
9.4 Latin America Bio-identical Hormone Replacement Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bio-identical Hormone Replacement Therapy Market Size (2019-2030)
10.2 Middle East & Africa Bio-identical Hormone Replacement Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Bio-identical Hormone Replacement Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Bio-identical Hormone Replacement Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 RevitaLife
11.1.1 RevitaLife Company Detail
11.1.2 RevitaLife Business Overview
11.1.3 RevitaLife Bio-identical Hormone Replacement Therapy Introduction
11.1.4 RevitaLife Revenue in Bio-identical Hormone Replacement Therapy Business (2019-2024)
11.1.5 RevitaLife Recent Development
11.2 SottoPelle
11.2.1 SottoPelle Company Detail
11.2.2 SottoPelle Business Overview
11.2.3 SottoPelle Bio-identical Hormone Replacement Therapy Introduction
11.2.4 SottoPelle Revenue in Bio-identical Hormone Replacement Therapy Business (2019-2024)
11.2.5 SottoPelle Recent Development
11.3 JumpstartMD
11.3.1 JumpstartMD Company Detail
11.3.2 JumpstartMD Business Overview
11.3.3 JumpstartMD Bio-identical Hormone Replacement Therapy Introduction
11.3.4 JumpstartMD Revenue in Bio-identical Hormone Replacement Therapy Business (2019-2024)
11.3.5 JumpstartMD Recent Development
11.4 BioTE Medical
11.4.1 BioTE Medical Company Detail
11.4.2 BioTE Medical Business Overview
11.4.3 BioTE Medical Bio-identical Hormone Replacement Therapy Introduction
11.4.4 BioTE Medical Revenue in Bio-identical Hormone Replacement Therapy Business (2019-2024)
11.4.5 BioTE Medical Recent Development
11.5 Aesthetic Everything
11.5.1 Aesthetic Everything Company Detail
11.5.2 Aesthetic Everything Business Overview
11.5.3 Aesthetic Everything Bio-identical Hormone Replacement Therapy Introduction
11.5.4 Aesthetic Everything Revenue in Bio-identical Hormone Replacement Therapy Business (2019-2024)
11.5.5 Aesthetic Everything Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
